Ammara Mushtaq, MD
Clinical Assistant Professor
Department:
MD-INFECTIOUS DISEASES
Business Phone:
(352) 294-5481
Business Email:
ammara.mushtaq@medicine.ufl.edu
About Ammara Mushtaq
Dr. Mushtaq specializes in treatment of general infectious diseases and HIV. Dr. Mushtaq has special interest in treatment of difficult-to treat bacterial infections causing pneumonia, bacteremia, meningitis, skin and soft tissue infections, osteomyelitis, endocarditis and septic arthritis, among others. Other clinical interests include healthcare-associated infections, sepsis, and outpatient parenteral antibiotic therapy (OPAT).
Dr. Mushtaq’s research interests are to understand epidemiology, diagnosis and therapeutics of infections caused by multidrug-resistant Gram-negative bacteria, and antimicrobial stewardship. She collaborates with genomic scientists and microbiologists to understand the genetic context of such drug-resistant bacteria. She has international outreach and collaborations with researchers in the UK and Pakistan to address some of the key questions to improve our understanding of how antibiotic resistant Gram-negative bacteria spread and cause infections. Her current efforts are focused on developing an antimicrobial resistance surveillance network in Southeast Asia. Dr. Mushtaq’s work has been published in reputed journals and books, and has been cited.
Accomplishments
Ambulatory resident of the year
2016-2017
·
Department of Medicine, Detroit Medical Center
ASM Student and Postdoc travel grant for ASM Microbe 2016
2016
·
American Society of Microbiology
Elected to participate in 64th Lindau Nobel Laureates Meeting in Medicine or Physiology
2014
·
Lindau Council, Germany
Irfan A. Khan Memorial Merit Award for outstanding dedication in the field of medicine
2014
·
Dow Graduate Association of North America (DOGANA)
Overseas scholarship
2012
·
British Society of Antimicrobial Chemotherapy for researchCardiff University, UK
Board Certifications
-
Infectious DiseasesAmerican Board of Internal Medicine
-
Internal MedicineAmerican Board of Internal Medicine
Clinical Profile
Specialties
- Infectious Disease
Areas of Interest
- Asymptomatic HIV infection
- Asymptomatic bacteriuria
- Bacterial gastroenteritis
- Blood culture
- Cellulitis
- Ear infection – acute
- Ear infection – chronic
- Endocarditis
- Epidural abscess
- Gram-negative meningitis
- Infectious endocarditis
- Osteomyelitis
- Pseudomembranous colitis
- Sepsis
- Septic arthritis
- Septic shock
- Sexually Transmitted Diseases (STD)
- Sputum Gram stain
- Surgical wound infection – treatment
- Urinary tract infection – adults
Research Profile
Areas of Interest
- Antimicrobial stewardship
- Development of novel antibiotics
- Dual-carbapenemase producing bacteria
- Metallo-β-lactamase producing Gram-negative bacteria
- Pathogenesis of carbapenem-resistant Enterobacterales
- Pseudomonas aeruginosa and Acinetobacter baumannii
- Surveillance of antimicrobial resistance in developing countries
Publications
2024
Alemnew Dagnew-developing a new TB vaccine.
The Lancet. Infectious diseases.
24(4)
[DOI] 10.1016/S1473-3099(24)00163-4.
[PMID] 38519258.
2024
Galvanised by tragedy: Elizabeth Bankah.
The Lancet. Child & adolescent health.
8(4)
[DOI] 10.1016/S2352-4642(24)00055-5.
[PMID] 38485410.
2023
A new antifungal drug for candidaemia.
The Lancet. Infectious diseases.
23(6)
[DOI] 10.1016/S1473-3099(23)00307-9.
[PMID] 37244278.
2023
CROI 2023.
The Lancet. Infectious diseases.
23(4)
[DOI] 10.1016/S1473-3099(23)00150-0.
[PMID] 36965497.
2023
Highlights from SHEA 2023.
The Lancet. Infectious diseases.
23(6)
[DOI] 10.1016/S1473-3099(23)00303-1.
[PMID] 37244274.
2023
John Schieffelin-fighting viral haemorragic fevers.
The Lancet. Infectious diseases.
23(11)
[DOI] 10.1016/S1473-3099(23)00639-4.
[PMID] 37839423.
2023
Lenacapavir: a new treatment of resistant HIV-1 infections.
The Lancet. Infectious diseases.
23(3)
[DOI] 10.1016/S1473-3099(23)00075-0.
[PMID] 36841248.
2023
Leyla Ismayilova: healing with words instead of pills.
The Lancet. Child & adolescent health.
7(4)
[DOI] 10.1016/S2352-4642(23)00057-3.
[PMID] 36948661.
2023
Marta Boffito-The happy warrior.
The Lancet. Infectious diseases.
23(8)
[DOI] 10.1016/S1473-3099(23)00441-3.
[PMID] 37507152.
2023
Minoarisoa Rajerison-fighting plague in Madagascar.
The Lancet. Infectious diseases.
23(2)
[DOI] 10.1016/S1473-3099(22)00860-X.
[PMID] 36549310.
2023
Sulbactam-durlobactam for Acinetobacter pneumonia.
The Lancet. Infectious diseases.
23(8)
[DOI] 10.1016/S1473-3099(23)00450-4.
[PMID] 37516133.
2022
“It’s worth a shot… or is it?” Notes from the grassroots on vaccine hesitancy and bridging gaps.
Infection control and hospital epidemiology.
43(11):1750-1752
[DOI] 10.1017/ice.2021.356.
[PMID] 34338180.
2022
Alexandra King-promoting Indigenous self-determination.
The Lancet. Infectious diseases.
22(2)
[DOI] 10.1016/S1473-3099(22)00019-6.
[PMID] 35092799.
2022
ASM Microbe 2022.
The Lancet. Infectious diseases.
22(8)
[DOI] 10.1016/S1473-3099(22)00457-1.
[PMID] 35870458.
2022
Cheryl Cohen-promoting evidence-based health policy.
The Lancet. Infectious diseases.
22(3)
[DOI] 10.1016/S1473-3099(22)00078-0.
[PMID] 35218755.
2022
Correlation between Identification of β-Lactamase Resistance Genes and Antimicrobial Susceptibility Profiles in Gram-Negative Bacteria: a Laboratory Data Analysis.
Microbiology spectrum.
10(2)
[DOI] 10.1128/spectrum.01485-21.
[PMID] 35254140.
2022
Infectious diseases compensation in the USA: the relative value.
The Lancet. Infectious diseases.
22(8):1106-1108
[DOI] 10.1016/S1473-3099(22)00360-7.
[PMID] 35716701.
2022
Najwa Khuri-Bulos-leading paediatric care in the Arab world.
The Lancet. Infectious diseases.
22(6)
[DOI] 10.1016/S1473-3099(22)00298-5.
[PMID] 35643109.
2022
O N Ray Bignall II: advocating for health equity.
The Lancet. Child & adolescent health.
6(12)
[DOI] 10.1016/S2352-4642(22)00274-7.
[PMID] 36115380.
2022
SHEA Spring Conference 2022.
The Lancet. Infectious diseases.
22(6)
[DOI] 10.1016/S1473-3099(22)00300-0.
[PMID] 35643101.
2022
Updates in pre-exposure prophylaxis for HIV.
The Lancet. Infectious diseases.
22(3)
[DOI] 10.1016/S1473-3099(22)00081-0.
[PMID] 35218750.
2022
Updates in sepsis management.
The Lancet. Infectious diseases.
22(1)
[DOI] 10.1016/S1473-3099(21)00773-8.
[PMID] 34953551.
2021
Adolescents navigating the COVID-19 pandemic.
The Lancet. Child & adolescent health.
5(10):692-693
[DOI] 10.1016/S2352-4642(21)00279-0.
[PMID] 34536359.
2021
CROI 2021.
The Lancet. Infectious diseases.
21(5)
[DOI] 10.1016/S1473-3099(21)00214-0.
[PMID] 33894841.
2021
Development of cavitary lung disease as a long-term complication of coronavirus disease 2019 in a young previously healthy patient: a case report.
Journal of medical case reports.
15(1)
[DOI] 10.1186/s13256-021-02961-9.
[PMID] 34256831.
2021
ECCMID 2021.
The Lancet. Infectious diseases.
21(9)
[DOI] 10.1016/S1473-3099(21)00487-4.
[PMID] 34450069.
2021
IDWeek 2021.
The Lancet. Infectious diseases.
21(11)
[DOI] 10.1016/S1473-3099(21)00634-4.
[PMID] 34717807.
2021
Lemierre’s syndrome associated with hypervirulent Klebsiella pneumoniae: A case report and genomic characterization of the isolate.
IDCases.
25
[DOI] 10.1016/j.idcr.2021.e01173.
[PMID] 34141583.
2021
Loretta Sweet Jemmott-a voice for the voiceless.
The Lancet. Infectious diseases.
21(6)
[DOI] 10.1016/S1473-3099(21)00282-6.
[PMID] 34051191.
2021
New guidelines for Lyme disease diagnosis.
The Lancet. Infectious diseases.
21(2)
[DOI] 10.1016/S1473-3099(21)00009-8.
[PMID] 33515521.
2021
Primary care of patients with HIV.
The Lancet. Infectious diseases.
21(1)
[DOI] 10.1016/S1473-3099(20)30925-7.
[PMID] 33271066.
2021
SHEA Spring 2021.
The Lancet. Infectious diseases.
21(6)
[DOI] 10.1016/S1473-3099(21)00276-0.
[PMID] 34051185.
2021
Updates on management of STIs.
The Lancet. Infectious diseases.
21(10)
[DOI] 10.1016/S1473-3099(21)00572-7.
[PMID] 34562397.
2021
World Microbe Forum 2021.
The Lancet. Infectious diseases.
21(8)
[DOI] 10.1016/S1473-3099(21)00409-6.
[PMID] 34331880.
2020
IDWeek 2020.
The Lancet. Infectious diseases.
20(12)
[DOI] 10.1016/S1473-3099(20)30875-6.
[PMID] 33248035.
2020
New guidelines for latent tuberculosis.
The Lancet. Infectious diseases.
20(4)
[DOI] 10.1016/S1473-3099(20)30181-X.
[PMID] 32222207.
2020
New guidelines to treat bacterial infections.
The Lancet. Infectious diseases.
20(11)
[DOI] 10.1016/S1473-3099(20)30799-4.
[PMID] 33098778.
2020
Switching to biosimilars: boon or bust?
The lancet. Gastroenterology & hepatology.
5(4):341-342
[DOI] 10.1016/S2468-1253(20)30044-3.
[PMID] 32183981.
2019
Breakthrough in the treatment of drug-resistant tuberculosis.
The Lancet. Respiratory medicine.
7(12)
[DOI] 10.1016/S2213-2600(19)30376-5.
[PMID] 31607588.
2019
Correction for Schmidt-Malan et al., “In Vitro Activity of Imipenem-Relebactam and Ceftolozane-Tazobactam against Resistant Gram-Negative Bacilli”.
Antimicrobial agents and chemotherapy.
63(2)
[DOI] 10.1128/AAC.02563-18.
[PMID] 30696694.
2019
Corrigendum to “Clinical significance of coryneform Gram-positive rods from blood identified by MALDI-TOF mass spectrometry and their susceptibility profiles – a retrospective chart review” [Diagn Microbiol Infect Dis 2016;85(3):372-376].
Diagnostic microbiology and infectious disease.
94(1)
[DOI] 10.1016/j.diagmicrobio.2019.02.002.
[PMID] 30857915.
2019
Progress needed in bronchopulmonary dysplasia.
The Lancet. Respiratory medicine.
7(4):300-301
[DOI] 10.1016/S2213-2600(19)30075-X.
[PMID] 30833220.
2019
Pulmonary complications of influenza infection: a targeted narrative review.
Postgraduate medicine.
131(5):299-308
[DOI] 10.1080/00325481.2019.1592400.
[PMID] 30845866.
2019
Repeating blood cultures after initial bacteremia: When and how often?
Cleveland Clinic journal of medicine.
86(2):89-92
[DOI] 10.3949/ccjm.86a.18001.
[PMID] 30742578.
2019
The addiction paradox.
The Lancet. Child & adolescent health.
3(2)
[DOI] 10.1016/S2352-4642(18)30371-7.
[PMID] 30470670.
2019
Tuberculosis in diabetes: insidious and neglected.
The Lancet. Respiratory medicine.
7(6)
[DOI] 10.1016/S2213-2600(19)30119-5.
[PMID] 31003965.
2018
Asthma in the USA: the good, the bad, and the disparity.
The Lancet. Respiratory medicine.
6(5):335-336
[DOI] 10.1016/S2213-2600(18)30143-7.
[PMID] 29625773.
2018
Baloxavir: game-changer or much ado about nothing?
The Lancet. Respiratory medicine.
6(12):903-904
[DOI] 10.1016/S2213-2600(18)30469-7.
[PMID] 30420246.
2018
Comparison of complications in midlines versus central venous catheters: Are midlines safer than central venous lines?
American journal of infection control.
46(7):788-792
[DOI] 10.1016/j.ajic.2018.01.006.
[PMID] 29525366.
2018
COPD and rural health in the USA.
The Lancet. Respiratory medicine.
6(5):330-331
[DOI] 10.1016/S2213-2600(18)30142-5.
[PMID] 29605623.
2018
Impact of a Multidisciplinary Infection Prevention Initiative on Central Line and Urinary Catheter Utilization in a Long-term Acute Care Hospital.
Open forum infectious diseases.
5(7)
[DOI] 10.1093/ofid/ofy156.
[PMID] 30090837.
2018
In Vitro Activity of Imipenem-Relebactam and Ceftolozane-Tazobactam against Resistant Gram-Negative Bacilli
Antimicrob Agents Chemother.
62(8):e00533-18
2018
In Vitro Activity of Imipenem-Relebactam and Ceftolozane-Tazobactam against Resistant Gram-Negative Bacilli.
Antimicrobial agents and chemotherapy.
62(8)
[DOI] 10.1128/AAC.00533-18.
[PMID] 29760145.
2018
Investigating pneumonia-a neglected tragedy.
The Lancet. Respiratory medicine.
[DOI] 10.1016/S2213-2600(18)30186-3.
[PMID] 29706506.
2018
New clinical recommendations for Clostridium difficile.
The Lancet. Infectious diseases.
18(4)
[DOI] 10.1016/S1473-3099(18)30180-4.
[PMID] 29582768.
2018
United to end tuberculosis.
The Lancet. Respiratory medicine.
6(11):818-819
[DOI] 10.1016/S2213-2600(18)30416-8.
[PMID] 30297271.
2017
Implementing an antibiotic stewardship program at a long-term acute care hospital in Detroit, Michigan.
American journal of infection control.
45(12):e157-e160
[DOI] 10.1016/j.ajic.2017.07.028.
[PMID] 29031431.
2017
Updates in tuberculosis diagnosis in the USA.
The Lancet. Infectious diseases.
17(2):147-148
[DOI] 10.1016/S1473-3099(17)30018-X.
[PMID] 28134117.
2016
Clinical significance of coryneform Gram-positive rods from blood identified by MALDI-TOF mass spectrometry and their susceptibility profiles – a retrospective chart review
Diagn Microbiol Infect Dis ..
85(3):372-376
2016
Clinical significance of coryneform Gram-positive rods from blood identified by MALDI-TOF mass spectrometry and their susceptibility profiles – a retrospective chart review.
Diagnostic microbiology and infectious disease.
85(3):372-376
[DOI] 10.1016/j.diagmicrobio.2016.04.013.
[PMID] 27179368.
2016
Differential Antimicrobial Susceptibilities of Granulicatella adiacens and Abiotrophia defectiva
Antimicrob Agents Chemother.
60(8):5036-5039
2016
Differential Antimicrobial Susceptibilities of Granulicatella adiacens and Abiotrophia defectiva.
Antimicrobial agents and chemotherapy.
60(8):5036-9
[DOI] 10.1128/AAC.00485-16.
[PMID] 27216060.
2016
FDA approves broad hepatitis C treatment.
The Lancet. Infectious diseases.
16(10):1118-1119
[DOI] 10.1016/S1473-3099(16)30344-9.
[PMID] 27676353.
2016
Highlights from ASM Microbe 2016.
The Lancet. Infectious diseases.
16(8):898-9
[DOI] 10.1016/S1473-3099(16)30225-0.
[PMID] 27477984.
2016
Highlights from the 26th ECCMID.
The Lancet. Infectious diseases.
16(6):645-647
[DOI] 10.1016/S1473-3099(16)30094-9.
[PMID] 27301925.
2016
Training in infectious diseases-any takers?
The Lancet. Infectious diseases.
16(6):648-649
[DOI] 10.1016/S1473-3099(16)30095-0.
[PMID] 27301926.
2016
UN commits to tackling antimicrobial resistance.
The Lancet. Infectious diseases.
16(11):1229-1230
[DOI] 10.1016/S1473-3099(16)30419-4.
[PMID] 27788986.
2015
Characterization of plasmids in extensively drug-resistant acinetobacter strains isolated in India and Pakistan.
Antimicrobial agents and chemotherapy.
59(2):923-9
[DOI] 10.1128/AAC.03242-14.
[PMID] 25421466.
2015
Highlights from the 25th ECCMID.
The Lancet. Infectious diseases.
15(6):639-40
[DOI] 10.1016/S1473-3099(15)00010-9.
[PMID] 26008841.
2015
Rates of caesarian section and trials and success of vaginal birth after caesarean sections in secondary care hospital.
JPMA. The Journal of the Pakistan Medical Association.
65(1):81-3
[PMID] 25831682.
2015
Solithromycin to treat community-acquired pneumonia?
The Lancet. Respiratory medicine.
3(6)
[DOI] 10.1016/S2213-2600(15)00188-5.
[PMID] 25963714.
2015
Use of Corticosteroids in the management of Idiopathic Pulmonary Haemosiderosis: Do we have enough evidence.
Pakistan journal of medical sciences.
31(2):487-9
[DOI] 10.12669/pjms.312.7135.
[PMID] 26101518.
2014
Characterization of plasmids in extensively drug-resistant acinetobacter strains isolated in India and Pakistan
Antimicrob Agents Chemother.
59(2):923-929
2014
Inpatient satisfaction at tertiary care public hospitals of a metropolitan city of Pakistan.
JPMA. The Journal of the Pakistan Medical Association.
64(12):1392-7
[PMID] 25842585.
2014
The right to live or die? A perspective on voluntary euthanasia.
Pakistan journal of medical sciences.
30(5):1159-60
[DOI] 10.12669/pjms.305.5777.
[PMID] 25225548.
2013
Anita Zaidi: promoting newborn and child health in Pakistan.
Lancet (London, England).
381(9884)
[DOI] 10.1016/S0140-6736(13)61427-0.
[PMID] 23791335.
2013
Current efficacy of antibiotics against Klebsiella isolates from urine samples – a multi-centric experience in Karachi.
Pakistan journal of pharmaceutical sciences.
26(1):11-5
[PMID] 23261722.
2013
Gastroschisis.
Journal of the College of Physicians and Surgeons–Pakistan : JCPSP.
23(6):432-3
[PMID] 23763807.
2013
Incidence and outcome of small for gestational age foetuses: an experience from a secondary care hospital.
JPMA. The Journal of the Pakistan Medical Association.
63(11):1422-4
[PMID] 24392532.
2013
Is fetal brain Doppler effective in predicting risks of caesarean delivery?
Journal of the College of Physicians and Surgeons–Pakistan : JCPSP.
23(6):451-2
[PMID] 23763815.
2013
Islamic law: Backing up forensic DNA evidence.
Nature.
503(7476)
[DOI] 10.1038/503342b.
[PMID] 24256796.
2013
Meckel Gruber Syndrome: Second trimester diagnosis of a case in a non-consanguineous marriage.
Pakistan journal of medical sciences.
29(1):234-6
[DOI] 10.12669/pjms.291.2930.
[PMID] 24353549.
2013
Oesophageal duplication cyst presenting as haemoptysis.
JPMA. The Journal of the Pakistan Medical Association.
63(5):633-4
[PMID] 23757996.
2012
Assessment of research output at higher level of educaton in Pakistan.
JPMA. The Journal of the Pakistan Medical Association.
62(6):628-32
[PMID] 22755361.
2012
Developmental milestones: do the parents know enough?
JPMA. The Journal of the Pakistan Medical Association.
62(9)
[PMID] 23139998.
2012
Frequency of HBsAg positivity: a laboratory data analysis.
Journal of the College of Physicians and Surgeons–Pakistan : JCPSP.
22(11):742-3
[PMID] 23146863.
2012
Hand hygiene does work.
The Lancet. Infectious diseases.
12(11):828-9
[DOI] 10.1016/S1473-3099(12)70235-9.
[PMID] 23099078.
2012
Idiopathic pulmonary haemosiderosis presenting as severe iron deficiency anaemia–a case from Pakistan.
JPMA. The Journal of the Pakistan Medical Association.
62(8):845-7
[PMID] 23862264.
2012
Is prophylactic antibiotic treatment justified in neonates?
JPMA. The Journal of the Pakistan Medical Association.
62(8):856-7
[PMID] 23862269.
2012
Malnutrition in Pakistani children, its causes, consequences and recommendations.
JPMA. The Journal of the Pakistan Medical Association.
62(3)
[PMID] 22764481.
2012
Medical students and medical research in Pakistan.
JPMA. The Journal of the Pakistan Medical Association.
62(5):527-8
[PMID] 22755331.
2012
Relationship between blood groups and ulcers: revisiting the pioneer work.
JPMA. The Journal of the Pakistan Medical Association.
62(12)
[PMID] 23866501.
2012
Skin tag (acrochordon) on labium majus in an infertile female.
Journal of the College of Physicians and Surgeons–Pakistan : JCPSP.
22(9):613-4
[PMID] 22980625.
Grants
Jan 2023
– Oct 2023
The Burden of Antibiotic Resistance in Neonates from Developing Societies (BARNARDS) and 2) : The Burden of Antimicrobial Resistance and Antibiotic Treatment Failure in Low-, Middle- and High-Income Countries (BALANCE)
Role: Principal Investigator
Funding: UNIVERSITY OF OXFORD
Education
Fellowship – Infectious diseases
2019-2021
·
Icahn School of Medicine at Mount Sinai, New York
Residency – Internal Medicine
2016-2019
·
Wayne State University/Detroit Medical Center
Research Trainee – Infectious diseases
2015-2016
·
Infectious Diseases Research Laboratory at Mayo Clinic, Rochester
Medical Degree
2009-2015
·
Dow Medical College, Dow University of Health Sciences, Pakistan
Contact Details
Phones:
- Business:
- (352) 294-5481
Emails:
- Business:
- ammara.mushtaq@medicine.ufl.edu
Addresses:
- Business Mailing:
-
PO Box 100289
GAINESVILLE FL 32610 - Business Street:
-
1600 SW ARCHER RD
GAINESVILLE FL 32610